Startup India Government of India
Ramdular Pharmaceutical Private Limited - pharma in Ratnagiri, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹46.44 Lakh
▲ 7% YoY
Net profit · FY 2024
₹79,351
Net margin 1.7%
EBITDA · FY 2024
₹79,351
EBITDA margin 1.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
3
Provident fund records
Directors on board
2
As per MCA filings
About Ramdular Pharmaceutical Private Limited
Data last updated:
Ramdular Pharmaceutical Private Limited is a private limited company based in Ratnagiri, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC296654. Its GSTIN is 27AAICR3769G1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aditya Ramdular Jaiswal and Sanjeev Ramdular Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.1092 Ehsan Villa Padavekar Colony Udyamnagar, Ratnagiri, Maharashtra, India – 415612.
As per the financials filed for FY 2024, the company reported a revenue of ₹46.44 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹79,351 (net margin 1.7%) and EBITDA of ₹79,351 (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 92% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
Ramdular Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0223424). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ramdularpharma.com.
Company Details of Ramdular Pharmaceutical Private Limited
CIN U74999MH2017PTC296654
Registration Number 296654
Incorporation Date 27 June 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0223424
Recognitions & Rankings of Ramdular Pharmaceutical
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0223424
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo.1092 Ehsan Villa Padavekar Colony Udyamnagar, Ratnagiri, Maharashtra, India – 415612
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Ramdular Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Ramdular Pharmaceutical Private Limited
The main business activity of Ramdular Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ramdular Pharmaceutical Private Limited FY 2024 filings available
Ramdular Pharmaceutical Private Limited reported revenue of ₹46.44 Lakh (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹46.44 Lakh ▲ 7%
Net profit · FY 2024
₹79,351 margin 1.7%
EBITDA · FY 2024
₹79,351 margin 1.7%
Compounded Annual Growth Rate (CAGR) of Ramdular Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 17%
5 years · compounded
▲ 92%
EBITDA CAGR growth
1 year
▼ 90%
3 years · compounded
▼ 2%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 92% over five years, including 7% growth in the latest year. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ramdular Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹79,351 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹79,351 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ramdular Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ramdular Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Ramdular Jaiswal | Director | 27 Jun 2017 | 9 Years 3 Months | Current |
| Sanjeev Ramdular Jaiswal | Director | 16 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medifern India Lifesciences Private Limited | ₹46.83 Lakh (FY 2025) | •••• | •••• | 144.0% | •••• | Panvel, Maharashtra, India |
| Raciwell Pharma Private Limited | ₹46.82 Lakh (FY 2023) | •••• | •••• | -55.0% | •••• | Mumbai, Maharashtra, India |
| Agro Tech Aromatics Private Limited | ₹46.78 Lakh (FY 2025) | •••• | •••• | 508.0% | •••• | Jammu, Jammu and Kashmir, India |
| Cellexa Lifesciences Private Limited | ₹46.5 Lakh (FY 2025) | •••• | •••• | 57.0% | •••• | Maharashtra, India |
| Edvenswa Pharmaceuticals Private Limited | ₹46.5 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Hyderabad, Telangana, India |
| Ramdular Pharmaceutical Private Limited this company | ₹46.44 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Ratnagiri, Maharashtra, India |
| Hayai Pharma Private Limited | ₹46.43 Lakh (FY 2024) | •••• | •••• | 786.0% | •••• | Meerut, Uttar Pradesh, India |
| VTX Formulations Private Limited | ₹46.42 Lakh (FY 2024) | •••• | •••• | 266.0% | •••• | Dehradun, Uttarakhand, India |
| Esan Pharmaceuticals Private Limited | ₹46.41 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | New Delhi, Delhi, India |
| Prolific Labs Private Limited | ₹46.34 Lakh (FY 2024) | •••• | •••• | -16.0% | •••• | New Delhi, Delhi, India |
| Esken Pharmaceuticals Limited | ₹46.28 Lakh (FY 2024) | •••• | •••• | 26.0% | •••• | Gujarat, India |
Peers are the five companies nearest above and the five nearest below Ramdular Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical Private Limited is audited by BJS&CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BJS&CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ramdular Pharmaceutical Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ramdular Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Ramdular Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Sanjeev Ramdular Jaiswal ceased to be Additional Director on 30 Sep 2019.
AGM
Ramdular Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ramdular Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Sanjeev Ramdular Jaiswal ceased to be Additional Director.
Ceased
Arun Ramdular Jaiswal ceased to be Director.
Appointed
Sanjeev Ramdular Jaiswal was appointed as Director.
Appointed
Aditya Ramdular Jaiswal was appointed as Director.
Incorporation
27 Jun 2017
Ramdular Pharmaceutical Private Limited was registered on 27 Jun 2017 with Roc Mumbai & aged 9 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Ramdular Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ramdular Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ramdular Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR3769G1ZZ | Maharashtra | Active | 29 Aug 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ramdular Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramdular Pharmaceutical Private Limited
Ramdular Pharmaceutical is an active private limited company based in Ratnagiri, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 June 2017 (9+ years old) and is registered under CIN U74999MH2017PTC296654.
Ramdular Pharmaceutical reported revenue of ₹46.44 Lakh for FY 2024 (up 7% YoY).
Ramdular Pharmaceutical has 2 current directors:
- Aditya Ramdular Jaiswal - Director
- Sanjeev Ramdular Jaiswal - Director
Ramdular Pharmaceutical reported a net profit of ₹79,351 (net margin 1.7%) and EBITDA of ₹79,351 (EBITDA margin 1.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ramdular Pharmaceutical is 17% over three years and 92% over five years. In the latest year (FY 2024) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ramdular Pharmaceutical is 27AAICR3769G1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ramdular Pharmaceutical is U74999MH2017PTC296654. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ramdular Pharmaceutical was incorporated on 27 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ramdular Pharmaceutical by revenue are Medifern India Lifesciences Private Limited, Raciwell Pharma Private Limited, Agro Tech Aromatics Private Limited, Cellexa Lifesciences Private Limited, Edvenswa Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Sanjeev Ramdular Jaiswal ceased to be Additional Director on 30 Sep 2019. Arun Ramdular Jaiswal ceased to be Director on 16 Feb 2019. Sanjeev Ramdular Jaiswal was appointed as Director on 16 Feb 2019. Ramdular Pharmaceutical has 4 board changes on record in total.
Yes, Ramdular Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).